Please login to the form below
Round Tables
-
New models of NHS care – new models of Pharma response?Chaired by the Group Editor of Pharmaceutical Market Europe (PME) Andrew McConaghie, join IQVIA and PME for an exclusive roundtable on how the UK pharmaceutical industry can engage with the NHS’ rapidly evolving organisations.
Featured jobs
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Account Director
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Account Supervisor
-
Salary TBC
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Account Executive
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Senior Medical Writer
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- FDA advisors say no to empagliflozin in type 1 diabetes
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- PMEA 2018 Photo Gallery - PMEA
- AbbVie sells $30bn of bonds ahead of Allergan merger
- Nucala works in rare inflammatory disease, says GSK
- Bayer, Merck’s high-risk heart failure drug comes good in phase 3
- Novartis changes focus in Shanghai from early research to drug development
- Karuna’s shares spike on schizophrenia drug data
- Alkermes boosts CNS presence with $950m Rodin acquisition
- Biogen under fire over $88,000 Vumerity annual price
- Rethinking trials: the pros and cons of protocol amendments
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Quick links
Infographics
